We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

TXG opened at $12.31 on Thursday. The stock has a market cap of $1.49 billion, a price-to-earnings ratio of -8.05 and a beta of 1.85. 10x Genomics has a 1 year low of $10.80 and a 1 year high of ...

NASDAQ TXG opened at $12.31 on Thursday. The stock’s 50 day moving average is $14.68 and its 200 day moving average is $17.35. The stock has a market cap of $1.49 billion, a PE ratio of -8.05 ...

Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The company’s shares closed yesterday at $11.94.

Barclays lowered the firm’s price target on 10x Genomics (TXG) to $15 from $18 and keeps an Overweight rating on the shares. Published first on TheFly – the ultimate source for real-time ...

Electric and hybrid car specialist BYD has detailed its new 'God's Eye' driver-assistance technology, which includes support for the DeepSeek artificial intelligence model.

Dan Brennan, Citi: Asked about growth drivers for 2024. CFO Taich highlighted robust demand for GEM-X and Visium HD, along with continued Xenium growth. Tejas Savant, Morgan Stanley: Questioned ...

10x Genomics Inc (NASDAQ:TXG) launched major new products across all three platforms, receiving a tremendous customer response. The company introduced new products in the single-cell portfolio ...